DexCom
DXCM
Collegium Pharmaceutical
COLL
Lantheus
LNTH
Cars.com
CARS
YETI Holdings
YETI
US Stock MarketDetailed Quotes
CNXC Concentrix
- 46.320
- +2.780+6.38%
Close Jan 3 16:00 ET
- 46.110
- -0.210-0.45%
Pre 05:55 ET
3.00BMarket Cap15.29P/E (TTM)
46.545High43.490Low563.89KVolume43.700Open43.540Pre Close25.79MTurnover1.35%Turnover Ratio8.13P/E (Static)64.82MShares103.93852wk High0.72P/B1.94BFloat Cap36.28052wk Low1.21Dividend TTM41.80MShs Float200.629Historical High2.61%Div YieldTTM7.02%Amplitude4.199Historical Low45.729Avg Price1Lot Size
Concentrix News
Scotiabank Maintains Concentrix(CNXC.US) With Buy Rating, Cuts Target Price to $65
Baird Maintains Concentrix(CNXC.US) With Buy Rating, Maintains Target Price $70
Concentrix Analyst Ratings
Baird Initiates Concentrix(CNXC.US) With Buy Rating, Announces Target Price $70
Concentrix Initiated With an Outperform at Baird
Concentrix Is Maintained at Buy by Canaccord Genuity
Concentrix Analyst Ratings
BofA Securities Maintains Concentrix(CNXC.US) With Hold Rating, Cuts Target Price to $70
Barrington Maintains Concentrix(CNXC.US) With Buy Rating, Cuts Target Price to $70
Barrington Research Adjusts Concentrix Price Target to $70 From $84, Maintains Outperform Rating
CCORF Maintains Concentrix(CNXC.US) With Buy Rating, Cuts Target Price to $100
Scotiabank Maintains Concentrix(CNXC.US) With Buy Rating, Maintains Target Price $85
Scotiabank Sticks to Their Buy Rating for Concentrix (CNXC)
Barrington Maintains Concentrix(CNXC.US) With Buy Rating, Maintains Target Price $84
Concentrix Is Maintained at Outperform by Barrington Research
Barrington Maintains Concentrix(CNXC.US) With Buy Rating, Maintains Target Price $84
Buy Rating Affirmed for Concentrix on Strong Market Position and Growth Prospects Amidst AI Automation Rise
Concentrix Raised to Neutral From Underperform by B of A Securities
Concentrix Analyst Ratings
BofA Securities Upgrades Concentrix(CNXC.US) to Hold Rating, Raises Target Price to $85